Res. Elgalley et al., RADICAL RADIOTHERAPY FOR LOCALIZED ADENOCARCINOMA OF THE PROSTATE - AREPORT OF 191 CASES, British Journal of Urology, 75(1), 1995, pp. 38-43
Objective To assess the results of radiotherapy in the treatment of lo
calized prostate cancer. End points for assessment were survival, loca
l control, development of metastases, and the toxicity of therapy. Mat
erials and methods The case notes of 191 patients who were treated wit
h radical radiotherapy between 1982 and 1992 were reviewed. The pathol
ogy of 130 patients was reviewed by a single pathologist. A multivaria
te analysis was performed to identify significant prognostic factors w
ith regard to survival and relapse. Results One-hundred and eighty-two
patients were assessable. The minimum length of follow-up was one yea
r (median=40 months). The actuarial cause-specific 5 and 10 year survi
val rates were 63% and 35% respectively. Local progression occurred in
41% of patients with 37% developing metastases. Multivariate statisti
cal analysis demonstrated that T stage and Gleason Score were signific
ant predictors for survival. Late complications were usually mild, wit
h only 4% developing serious bladder toxicity. Conclusion Radical radi
otherapy has a role in the curative treatment of prostate cancer. Surv
ival is significantly related to T stage at the time of presentation,
and to the Gleason Score of the tumour. Survival in this series was no
t as good as the best surgical series, but it is still not clear which
patients should receive radiotherapy and which surgery as their prima
ry management.